A growing number of patients have refractory angina - but limited therapeutic options. Revascularization, medical therapy, and risk factor modification have improved notably, but these patients are left with severe limitations in their quality of life. As described in this chapter, an increasing number of pharmacologic and nonpharmacologic approaches for no-option patients are making quality-of-life inroads for this challenging patient population.
|Original language||English (US)|
|Title of host publication||Coronary Heart Disease|
|Subtitle of host publication||Clinical, Pathological, Imaging, and Molecular Profiles|
|Number of pages||13|
|ISBN (Print)||1461414741, 9781461414742|
|State||Published - Jun 1 2012|